(19)
(11) EP 4 337 167 A2

(12)

(88) Date of publication A3:
26.01.2023

(43) Date of publication:
20.03.2024 Bulletin 2024/12

(21) Application number: 22728373.6

(22) Date of filing: 06.05.2022
(51) International Patent Classification (IPC): 
A61K 9/00(2006.01)
A61K 47/18(2017.01)
A61K 9/08(2006.01)
A61P 27/08(2006.01)
A61K 47/02(2006.01)
A61K 47/40(2006.01)
A61K 31/46(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 9/0048; A61K 47/02; A61K 47/183; A61K 47/40; A61K 31/46; A61K 9/08; A61P 27/08
(86) International application number:
PCT/EP2022/062273
(87) International publication number:
WO 2022/238251 (17.11.2022 Gazette 2022/46)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 10.05.2021 EP 21460024

(71) Applicant: Warszawskie Zaklady Farmaceutyczne Polfa S.A.
01-207 Warszawa (PL)

(72) Inventors:
  • PIETRZAK, Tomasz
    95-020 Wisniowa Góra (PL)
  • CEBULSKA, Ewelina
    05-650 Chynów (PL)
  • LUCZYNSKI, Pawe
    02-776 Warsaw (PL)
  • MAGNUSZEWSKA, Monika
    05-806 Nowa Wies Warszawska (PL)

(74) Representative: Kondrat, Mariusz 
Kondrat & Partners Al. Niepodleglosci 223/1
02-087 Warszawa
02-087 Warszawa (PL)

   


(54) OPHTHALMIC PHARMACEUTICAL COMPOSITION COMPRISING ATROPINE